Search

Your search keyword '"Stéphane Bouée"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Stéphane Bouée" Remove constraint Author: "Stéphane Bouée"
45 results on '"Stéphane Bouée"'

Search Results

1. Health economic impact of patients with phenylketonuria (PKU) in France – A nationwide study of health insurance claims data

2. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study

3. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

4. Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis

5. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

6. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

7. Diversité taxonomique des Hominidés fossiles en Asie : de nouvelles méthodes pour une vieille question

8. Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?

9. Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?

10. Asthma burden according to treatment steps in the French population-based cohort CONSTANCES

12. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM)

13. Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France

14. Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in

15. Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

16. Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database

17. Survey of Clinical Practice Patterns in the Management of 992 Hyperthyroid Patients in France

18. Qualité de vie des patients atteints de pneumopathie interstitielle diffuse associée à la sclérodermie systémique : impact de l’atteinte pulmonaire et des autres atteintes d’organes

20. Correction: Medico-economic comparison of two anticoagulant treatment strategies: Vitamin K antagonists vs. direct oral anticoagulants in older adults in nursing homes in France. The 'MIKADO' study.

21. Prevalence of Gout in the Adult Population of France

22. The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus

23. Traitements antidiabétiques des patients diabétiques de type 2 atteints d’une insuffisance rénale modérée ou sévère suivis en médecine générale en France

24. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

25. Characteristics and management of outpatients with history of or current atrial fibrillation: The observational French EPHA study

26. Bénéfice économique de Pradaxa® en thromboprophylaxie après prothèse totale de hanche ou de genou

27. Identification of patients with gout: elaboration of a questionnaire for epidemiological studies

28. Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era–concomitant gastroprotective therapy

29. Évolution du traitement de l’arthrose en médecine générale après la mise sur le marché des AINS anticox2 sélectifs et co-prescriptions de gastroprotecteurs

30. Épidémiologie de la fibrodysplasie ossifiante progressive (FOP) en France, croisement de deux bases de données

31. Medico-economic comparison of two anticoagulant treatment strategies: Vitamin K antagonists vs. direct oral anticoagulants in older adults in nursing homes in France. The 'MIKADO' study.

32. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients

33. Élaboration et passation en population générale d’un questionnaire visant à estimer la prévalence de la goutte en France

34. Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension

35. [Hypoglycemic treatment in type 2 diabetes patients suffering from moderate to severe renal failure in France. Aim of the study]

36. Biomechanical and psychosocial work exposures and musculoskeletal symptoms among vineyard workers

37. [Budget impact analysis of Pradaxa thromboprophylaxis after total hip or total knee replacement]

38. [Evaluation of a screening programme for diabetic retinopathy (DODIA study)]

39. [Invasive cervical cancer treatment costs in France]

40. Methodological issues in determining the dimensionality of composite health measures using principal component analysis: case illustration and suggestions for practice

41. SAT0544 Prevalence of Gout in the Adult Population of France in 2013

42. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.

44. An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.

45. Longitudinal data analysis, causality and care pathways : application to French nationwide claims database

Catalog

Books, media, physical & digital resources